These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1664420)

  • 1. Synthetic glucagon antagonists and partial agonists.
    Zechel C; Trivedi D; Hruby VJ
    Int J Pept Protein Res; 1991 Aug; 38(2):131-8. PubMed ID: 1664420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic linear and cyclic glucagon antagonists.
    Dharanipragada R; Trivedi D; Bannister A; Siegel M; Tourwe D; Mollova N; Schram K; Hruby VJ
    Int J Pept Protein Res; 1993 Jul; 42(1):68-77. PubMed ID: 8396562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of glucagon partial agonists and antagonists.
    Gysin B; Trivedi D; Johnson DG; Hruby VJ
    Biochemistry; 1986 Dec; 25(25):8278-84. PubMed ID: 3814583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor binding and adenylate cyclase activities of glucagon analogues modified in the N-terminal region.
    McKee RL; Pelton JT; Trivedi D; Johnson DG; Coy DH; Sueiras-Diaz J; Hruby VJ
    Biochemistry; 1986 Apr; 25(7):1650-6. PubMed ID: 3011069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low level cyclic adenosine 3',5'-monophosphate accumulation analysis of [des-His1, des- Phe6, Glu9] glucagon-NH2 identifies glucagon antagonists from weak partial agonists/antagonists.
    Van Tine BA; Azizeh BY; Trivedi D; Phelps JR; Houslay MD; Johnson DG; Hruby VJ
    Endocrinology; 1996 Aug; 137(8):3316-22. PubMed ID: 8754757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topographical amino acid substitution in position 10 of glucagon leads to antagonists/partial agonists with greater binding differences.
    Azizeh BY; Shenderovich MD; Trivedi D; Li G; Sturm NS; Hruby VJ
    J Med Chem; 1996 Jun; 39(13):2449-55. PubMed ID: 8691441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of two glucagon antagonists: receptor binding, adenylate cyclase, and effects on blood plasma glucose levels.
    Gysin B; Johnson DG; Trivedi D; Hruby VJ
    J Med Chem; 1987 Aug; 30(8):1409-15. PubMed ID: 3039134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New glucagon analogues with conformational restrictions and altered amphiphilicity: effects on binding, adenylate cyclase and glycogenolytic activities.
    Hruby VJ; Gysin B; Trivedi D; Johnson DG
    Life Sci; 1993; 52(10):845-55. PubMed ID: 8445980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon antagonists. Synthesis and inhibitory properties of Asp3-containing glucagon analogs.
    Andreu D; Merrifield RB
    Eur J Biochem; 1987 May; 164(3):585-90. PubMed ID: 3032623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of phenylalanine at position 6 in glucagon's mechanism of biological action: multiple replacement analogues of glucagon.
    Azizeh BY; Ahn JM; Caspari R; Shenderovich MD; Trivedi D; Hruby VJ
    J Med Chem; 1997 Aug; 40(16):2555-62. PubMed ID: 9258362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pure glucagon antagonists: biological activities and cAMP accumulation using phosphodiesterase inhibitors.
    Azizeh BY; Van Tine BA; Trivedi D; Hruby VJ
    Peptides; 1997; 18(5):633-41. PubMed ID: 9213355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity studies on the N-terminal region of glucagon.
    Sueiras-Diaz J; Lance VA; Murphy WA; Coy DH
    J Med Chem; 1984 Mar; 27(3):310-5. PubMed ID: 6699876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of the C-terminal alpha-helical structure for glucagon's biological activity.
    Krstenansky JL; Zechel C; Trivedi D; Hruby VJ
    Int J Pept Protein Res; 1988 Dec; 32(6):468-75. PubMed ID: 2854536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-function studies on positions 17, 18, and 21 replacement analogues of glucagon: the importance of charged residues and salt bridges in glucagon biological activity.
    Sturm NS; Lin Y; Burley SK; Krstenansky JL; Ahn JM; Azizeh BY; Trivedi D; Hruby VJ
    J Med Chem; 1998 Jul; 41(15):2693-700. PubMed ID: 9667960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of seven synthetic glucagon analogs, modified in position 1, 2 and/or 12, on liver and heart adenylate cyclase from rat.
    Robberecht P; Waelbroeck M; Camus JC; De Neef P; Coy DH; Christophe J
    Peptides; 1986; 7 Suppl 1():109-12. PubMed ID: 3018688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic peptide antagonists of glucagon.
    Unson CG; Andreu D; Gurzenda EM; Merrifield RB
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4083-7. PubMed ID: 3035568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor occupancy and adenylate cyclase activation in rat liver and heart membranes by 10 glucagon analogs modified in position 2,3, 4, 25, 27 and/or 29.
    Robberect P; Damien C; Moroder L; Coy DH; Wünsch E; Christophe J
    Regul Pept; 1988 May; 21(1-2):117-28. PubMed ID: 2839870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon: structure-function relationships investigated by sequence deletions.
    Frandsen EK; Grønvald FC; Heding LG; Johansen NL; Lundt BF; Moody AJ; Markussen J; Vølund A
    Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):665-77. PubMed ID: 6268519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
    Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
    Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity studies of hydrophobic amino acid replacements at positions 9, 11 and 16 of glucagon.
    Sturm NS; Hutzler AM; David CS; Azizeh BY; Trivedi D; Hruby VJ
    J Pept Res; 1997 Apr; 49(4):293-9. PubMed ID: 9176812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.